These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2429755)

  • 41. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y; Nakamura T; Nakanishi H; Oishi M; Hongo F; Okihara K; Mizutani S; Kuroda J; Ukimura O
    Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 44. Advanced testicular cancer: treatment choices in the "land of plenty".
    Garnick MB
    J Clin Oncol; 1985 Mar; 3(3):294-7. PubMed ID: 2579211
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
    Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
    Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 49. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
    Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
    J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
    Pizzocaro G; Pasi M; Salvioni R; Zanoni F; Milani A; Piva L
    Cancer; 1985 Nov; 56(10):2399-403. PubMed ID: 2412681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy.
    Hainsworth JD; Einhorn LH; Williams SD; Stewart M; Greco FA
    Ann Intern Med; 1982 Jul; 97(1):7-11. PubMed ID: 6178336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of testicular cancer: a new and improved model.
    Einhorn LH
    J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
    Raghavan D; Levi J; Thomson D; Harvey V
    Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
    [No Abstract]   [Full Text] [Related]  

  • 54. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.
    Ozols RF
    Prog Clin Biol Res; 1988; 269():419-27. PubMed ID: 2455910
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
    Motzer RJ; Cooper K; Geller NL; Bajorin DF; Dmitrovsky E; Herr H; Morse M; Fair W; Sogani P; Russo P
    Cancer; 1990 Dec; 66(12):2476-81. PubMed ID: 2174300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
    Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC
    J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of advanced testicular cancer].
    Murase T; Takashi M; Sobashima T; Shimoji T; Miyake K; Mitsuya H
    Hinyokika Kiyo; 1987 Jan; 33(1):47-50. PubMed ID: 2437779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
    Bassoulet J; Raoul Y; Garetta L
    Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
    Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
    J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.